The meeting report is available on the web !
International Symposium on Glyco-minded Biology of Diseases as a Basis of Pharmaceutical Sciences
Tats' hand-made poster was uploaded(2012.10.27)
Symposium photos were uploaded(2012.12. 5)
November 30 ~ December 1, 2012
Ito Memorial Hall
(Ito International Research Center, The University of Tokyo)
Hongo 7-3-1, Bunkyo-ku, Tokyo, Japan
Laboratory of Cancer Biology and Molecular Immunology, co-organized by
Global COE Program “Center for Medical System Innovation”, The University of Tokyo
and Core to Core Program, Japan Society for the Promotion of Science
Aim of the Symposium
(1) To review recent outstanding progress in the field of glycobiology, especially glycobiology related to diseases, immune disorders, and infection, (2) To provide opportunities for international communication to students and young researchers, (3) To inspire and to stimulate the attendants to excel in their future studies in pathology, biology and the pharmaceutical sciences.
Professor Tatsuro Irimura, Graduate School of Pharmaceutical Sciences, The University of Tokyo, has been enthusiastically involved in the research field of cancer, immunology and glycobiology and has demonstrated tireless efforts in order to bring up young researchers in an atmosphere of international crossover communication via The Pharmaceutical Society of Japan and the Global COE (Center of Excellence) Program of the University of Tokyo. The symposium is held also as a tribute on the occasion of his retirement.
Session 1 “Immune Disorders / Immunotherapy” reviews how carbohydrates and related molecules expressed on immune cells determine cellular interactions, cell identity and pathological phenotypes. The session provides a good inspiration on how to find novel therapeutic cues for immune related syndromes.
Session 2 “Cancer Biology / Functional Glycomics” reviews past and present oncology research as collaborative efforts in basic and clinical sciences and provides an outlook on the contribution of the pharmaceutical sciences.
Session 3 “Infectious Diseases / Dystroglycanopathies” reviews how mucins and other glycoconjugates expressed on microorganisms, viruses, and their host target epithelium regulate cellular interactions in the event of an infection. The session should inspire fruitful discussions on how to develop novel anti-infectious therapies.
Tatsuro Irimura(The University of Tokyo, Japan) : Special Lecture
Nicolai Bovin (Institute of Bioorganic Chemistry, Russian Academy of Sciences, Russia)
Henrik Clausen (University of Copenhagen, Denmark)
James W Dennis (Mount Sinai Hospital, Canada)
Tamao Endo (Tokyo Metropolitan Institute of Gerontology, Japan)
Olivera J Finn (University of Pittsburgh, USA)
Minoru Fukuda (Sanford-Burnham Medical Research Institute, USA)
Hideki Hasegawa (National Institute of Infectious Diseases, Japan)
Shohei Hori (RIKEN RCAI, Japan)
Jamey D Marth (Sanford-Burnham Medical Research Institute, USA)
Kouji Matsushima (The University of Tokyo, Japan)
Hisashi Narimatsu (National Institute of Advanced Industrial Science and Technology, Japan)
Gabriel A Rabinovich (National Council Research and University of Buenos Aires, Argentina)
Motoharu Seiki (The University of Tokyo, Japan)
Hideaki Tahara (The University of Tokyo, Japan)